COST-UTILITY ANALYSIS OF TOCILIZUMAB IN THE TREATMENT OF ACTIVE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

被引：1
|
作者：
Vicente, C. [1 ]
Sabapathy, S. [1 ]
Formica, L. [2 ]
Maturi, B. [2 ]
Piwko, C. [1 ]
机构：
[1] PIVINA Consulting Inc, Mississauga, ON, Canada
[2] F Hoffmann La Roche & Co Ltd, Mississauga, ON, Canada
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1142
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A225 / A225
页数：1
相关论文
共 50 条
  • [1] COST-UTILITY OF TOCILIZUMAB IN THE TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN FINLAND
    Hallinen, T.
    Soini, E. J.
    Diamantopoulos, A.
    Dejonckheere, F.
    Vihervaara, V.
    Hautala, A.
    Aalto, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 258 - 259
  • [2] Cost-utility and budget impact analysis of tocilizumab for the treatment of refractory systemic juvenile idiopathic arthritis in Thailand
    Kittiratchakool, Nitichen
    Kulpokin, Disorn
    Chanjam, Chonticha
    Vilaiyuk, Soamarat
    Charuvanij, Sirirat
    Phongsamart, Gun
    Khaosut, Parichat
    Tanya, Manasita
    Nanagara, Ratanavadee
    Nantapaisarn, Sira
    Leelahavarong, Pattara
    [J]. BMJ OPEN, 2020, 10 (09):
  • [3] TOCILIZUMAB IN POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS - A COST-UTILITY MODEL FOR THE UNITED KINGDOM
    Chang, S.
    Sawyer, L.
    Dejonckheere, F.
    van Suijlekom-Smit, L. W.
    Anink, J.
    Diamantopoulos, A.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A564 - A564
  • [4] Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
    Herlin, Troels
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (06) : 517 - 525
  • [5] Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
    Murakami, Miho
    Tomiita, Minako
    Nishimoto, Norihiro
    [J]. OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2012, 4 : 71 - 79
  • [6] Tocilizumab for Systemic Juvenile Idiopathic Arthritis
    Hagino, Noboru
    Yamaguchi, Ken-ichi
    Ohara, Yuri
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13): : 1256 - 1256
  • [7] Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis
    Zhang, Xiaoping
    Morcos, Peter N.
    Saito, Tomohisa
    Terao, Kimio
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (02) : 123 - 137
  • [8] Tocilizumab for the Treatment of Juvenile Idiopathic Arthritis
    Decelle, Kendra
    Horton, Evan R.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (06) : 822 - 829
  • [9] COST-UTILITY OF RHEUMATOID ARTHRITIS MONOTHERAPY WITH TOCILIZUMAB IN SPAIN
    Benito Ruiz, P.
    Navarro Sarabia, F.
    Gomez Reino, J.
    Poveda, J.
    Alvaro Gracia, J.
    Rubio-Rodriguez, D.
    Ruiz-Beato, E.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A565 - A565
  • [10] ECONOMIC EVALUATION OF TOCILIZUMAB FOR THE TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN MEXICO
    Carlos, F.
    Clark, P.
    Lechuga, D.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A309 - A309
12345